Early molecular response predicts outcomes in patients with chronic myeloid leukemia in chronic phase treated with frontline nilotinib or imatinib
Identifieur interne : 003A09 ( Main/Curation ); précédent : 003A08; suivant : 003A10Early molecular response predicts outcomes in patients with chronic myeloid leukemia in chronic phase treated with frontline nilotinib or imatinib
Auteurs : Timothy P. Hughes [Australie] ; Giuseppe Saglio [Italie] ; Hagop M. Kantarjian [États-Unis] ; François Guilhot [France] ; Dietger Niederwieser [Allemagne] ; Gianantonio Rosti [Italie] ; Chiaki Nakaseko [Japon] ; Carmino Antonio De Souza [Brésil] ; Matt E. Kalaycio [États-Unis] ; Stephan Meier [Suisse] ; Xiaolin Fan [États-Unis] ; Hans D. Menssen [Suisse] ; Richard A. Larson [États-Unis] ; Andreas Hochhaus [Allemagne]Source :
- Blood [ 0006-4971 ] ; 2014.
Abstract
More patients with chronic myeloid leukemia in chronic phase achieve EMR on frontline nilotinib than imatinib. EMR failure on frontline nilotinib or imatinib predicts poor outcomes in patients with chronic myeloid leukemia in chronic phase.
Url:
DOI: 10.1182/blood-2013-06-510396
PubMed: 24335106
PubMed Central: 4624459
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000172
- to stream Pmc, to step Curation: Pour aller vers cette notice dans l'étape Curation :000172
- to stream Pmc, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :001629
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :001655
- to stream Ncbi, to step Curation: Pour aller vers cette notice dans l'étape Curation :001655
- to stream Ncbi, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :001655
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :003A51
Links to Exploration step
PMC:4624459Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Early molecular response predicts outcomes in patients with chronic myeloid leukemia in chronic phase treated with frontline nilotinib or imatinib</title>
<author><name sortKey="Hughes, Timothy P" sort="Hughes, Timothy P" uniqKey="Hughes T" first="Timothy P." last="Hughes">Timothy P. Hughes</name>
<affiliation wicri:level="1"><nlm:aff id="aff1">South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, SA, Australia;</nlm:aff>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, SA</wicri:regionArea>
<wicri:noRegion>SA</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:aff id="aff2">Division of Haematology and Centre for Cancer Biology, South Australian Pathology, Adelaide, SA, Australia;</nlm:aff>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Division of Haematology and Centre for Cancer Biology, South Australian Pathology, Adelaide, SA</wicri:regionArea>
<wicri:noRegion>SA</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Saglio, Giuseppe" sort="Saglio, Giuseppe" uniqKey="Saglio G" first="Giuseppe" last="Saglio">Giuseppe Saglio</name>
<affiliation wicri:level="1"><nlm:aff id="aff3">University of Turin, Orbassano, Italy;</nlm:aff>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>University of Turin, Orbassano</wicri:regionArea>
<wicri:noRegion>Orbassano</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kantarjian, Hagop M" sort="Kantarjian, Hagop M" uniqKey="Kantarjian H" first="Hagop M." last="Kantarjian">Hagop M. Kantarjian</name>
<affiliation wicri:level="2"><nlm:aff id="aff4">The University of Texas MD Anderson Cancer Center, Houston, TX;</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Texas</region>
</placeName>
<wicri:cityArea>The University of Texas MD Anderson Cancer Center, Houston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Guilhot, Francois" sort="Guilhot, Francois" uniqKey="Guilhot F" first="François" last="Guilhot">François Guilhot</name>
<affiliation wicri:level="3"><nlm:aff id="aff5">Institut National de la Santé et de la Recherche Médicale Centre d'Investigation Clinique 0802, Centre Hospitalier Universitaire de Poitiers, Poitiers, France;</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut National de la Santé et de la Recherche Médicale Centre d'Investigation Clinique 0802, Centre Hospitalier Universitaire de Poitiers, Poitiers</wicri:regionArea>
<placeName><region type="region">Nouvelle-Aquitaine</region>
<region type="old region">Poitou-Charentes</region>
<settlement type="city">Poitiers</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Niederwieser, Dietger" sort="Niederwieser, Dietger" uniqKey="Niederwieser D" first="Dietger" last="Niederwieser">Dietger Niederwieser</name>
<affiliation wicri:level="1"><nlm:aff id="aff6">University of Leipzig, Leipzig, Saxony, Germany;</nlm:aff>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>University of Leipzig, Leipzig, Saxony</wicri:regionArea>
<wicri:noRegion>Saxony</wicri:noRegion>
<wicri:noRegion>Saxony</wicri:noRegion>
<wicri:noRegion>Saxony</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Rosti, Gianantonio" sort="Rosti, Gianantonio" uniqKey="Rosti G" first="Gianantonio" last="Rosti">Gianantonio Rosti</name>
<affiliation wicri:level="1"><nlm:aff id="aff7">University of Bologna, Bologna, Italy;</nlm:aff>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>University of Bologna, Bologna</wicri:regionArea>
<wicri:noRegion>Bologna</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Nakaseko, Chiaki" sort="Nakaseko, Chiaki" uniqKey="Nakaseko C" first="Chiaki" last="Nakaseko">Chiaki Nakaseko</name>
<affiliation wicri:level="1"><nlm:aff id="aff8">Chiba University Hospital, Chiba, Japan;</nlm:aff>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Chiba University Hospital, Chiba</wicri:regionArea>
<wicri:noRegion>Chiba</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="De Souza, Carmino Antonio" sort="De Souza, Carmino Antonio" uniqKey="De Souza C" first="Carmino Antonio" last="De Souza">Carmino Antonio De Souza</name>
<affiliation wicri:level="1"><nlm:aff id="aff9">University of Campinas, Campinas, Brazil;</nlm:aff>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>University of Campinas, Campinas</wicri:regionArea>
<wicri:noRegion>Campinas</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kalaycio, Matt E" sort="Kalaycio, Matt E" uniqKey="Kalaycio M" first="Matt E." last="Kalaycio">Matt E. Kalaycio</name>
<affiliation wicri:level="2"><nlm:aff id="aff10">Cleveland Clinic, Cleveland, OH;</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Ohio</region>
</placeName>
<wicri:cityArea>Cleveland Clinic, Cleveland</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Meier, Stephan" sort="Meier, Stephan" uniqKey="Meier S" first="Stephan" last="Meier">Stephan Meier</name>
<affiliation wicri:level="1"><nlm:aff id="aff11">Novartis Pharma AG, Basel, Switzerland;</nlm:aff>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Novartis Pharma AG, Basel</wicri:regionArea>
<wicri:noRegion>Basel</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Fan, Xiaolin" sort="Fan, Xiaolin" uniqKey="Fan X" first="Xiaolin" last="Fan">Xiaolin Fan</name>
<affiliation wicri:level="2"><nlm:aff id="aff12">Novartis Pharmaceuticals Corporation, East Hanover, NJ;</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">New Jersey</region>
</placeName>
<wicri:cityArea>Novartis Pharmaceuticals Corporation, East Hanover</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Menssen, Hans D" sort="Menssen, Hans D" uniqKey="Menssen H" first="Hans D." last="Menssen">Hans D. Menssen</name>
<affiliation wicri:level="1"><nlm:aff id="aff11">Novartis Pharma AG, Basel, Switzerland;</nlm:aff>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Novartis Pharma AG, Basel</wicri:regionArea>
<wicri:noRegion>Basel</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Larson, Richard A" sort="Larson, Richard A" uniqKey="Larson R" first="Richard A." last="Larson">Richard A. Larson</name>
<affiliation wicri:level="2"><nlm:aff wicri:cut="; and" id="aff13">University of Chicago, Chicago, IL</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Illinois</region>
</placeName>
<wicri:cityArea>University of Chicago, Chicago</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Hochhaus, Andreas" sort="Hochhaus, Andreas" uniqKey="Hochhaus A" first="Andreas" last="Hochhaus">Andreas Hochhaus</name>
<affiliation wicri:level="1"><nlm:aff id="aff14">Abteilung Hämatologie/Onkologie, Universitätsklinikum Jena, Jena, Thuringia, Germany</nlm:aff>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Abteilung Hämatologie/Onkologie, Universitätsklinikum Jena, Jena, Thuringia</wicri:regionArea>
<wicri:noRegion>Thuringia</wicri:noRegion>
<wicri:noRegion>Thuringia</wicri:noRegion>
<wicri:noRegion>Thuringia</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">24335106</idno>
<idno type="pmc">4624459</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4624459</idno>
<idno type="RBID">PMC:4624459</idno>
<idno type="doi">10.1182/blood-2013-06-510396</idno>
<date when="2014">2014</date>
<idno type="wicri:Area/Pmc/Corpus">000172</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000172</idno>
<idno type="wicri:Area/Pmc/Curation">000172</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000172</idno>
<idno type="wicri:Area/Pmc/Checkpoint">001629</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">001629</idno>
<idno type="wicri:Area/Ncbi/Merge">001655</idno>
<idno type="wicri:Area/Ncbi/Curation">001655</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001655</idno>
<idno type="wicri:doubleKey">0006-4971:2014:Hughes T:early:molecular:response</idno>
<idno type="wicri:Area/Main/Merge">003A51</idno>
<idno type="wicri:Area/Main/Curation">003A09</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Early molecular response predicts outcomes in patients with chronic myeloid leukemia in chronic phase treated with frontline nilotinib or imatinib</title>
<author><name sortKey="Hughes, Timothy P" sort="Hughes, Timothy P" uniqKey="Hughes T" first="Timothy P." last="Hughes">Timothy P. Hughes</name>
<affiliation wicri:level="1"><nlm:aff id="aff1">South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, SA, Australia;</nlm:aff>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, SA</wicri:regionArea>
<wicri:noRegion>SA</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:aff id="aff2">Division of Haematology and Centre for Cancer Biology, South Australian Pathology, Adelaide, SA, Australia;</nlm:aff>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Division of Haematology and Centre for Cancer Biology, South Australian Pathology, Adelaide, SA</wicri:regionArea>
<wicri:noRegion>SA</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Saglio, Giuseppe" sort="Saglio, Giuseppe" uniqKey="Saglio G" first="Giuseppe" last="Saglio">Giuseppe Saglio</name>
<affiliation wicri:level="1"><nlm:aff id="aff3">University of Turin, Orbassano, Italy;</nlm:aff>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>University of Turin, Orbassano</wicri:regionArea>
<wicri:noRegion>Orbassano</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kantarjian, Hagop M" sort="Kantarjian, Hagop M" uniqKey="Kantarjian H" first="Hagop M." last="Kantarjian">Hagop M. Kantarjian</name>
<affiliation wicri:level="2"><nlm:aff id="aff4">The University of Texas MD Anderson Cancer Center, Houston, TX;</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Texas</region>
</placeName>
<wicri:cityArea>The University of Texas MD Anderson Cancer Center, Houston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Guilhot, Francois" sort="Guilhot, Francois" uniqKey="Guilhot F" first="François" last="Guilhot">François Guilhot</name>
<affiliation wicri:level="3"><nlm:aff id="aff5">Institut National de la Santé et de la Recherche Médicale Centre d'Investigation Clinique 0802, Centre Hospitalier Universitaire de Poitiers, Poitiers, France;</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut National de la Santé et de la Recherche Médicale Centre d'Investigation Clinique 0802, Centre Hospitalier Universitaire de Poitiers, Poitiers</wicri:regionArea>
<placeName><region type="region">Nouvelle-Aquitaine</region>
<region type="old region">Poitou-Charentes</region>
<settlement type="city">Poitiers</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Niederwieser, Dietger" sort="Niederwieser, Dietger" uniqKey="Niederwieser D" first="Dietger" last="Niederwieser">Dietger Niederwieser</name>
<affiliation wicri:level="1"><nlm:aff id="aff6">University of Leipzig, Leipzig, Saxony, Germany;</nlm:aff>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>University of Leipzig, Leipzig, Saxony</wicri:regionArea>
<wicri:noRegion>Saxony</wicri:noRegion>
<wicri:noRegion>Saxony</wicri:noRegion>
<wicri:noRegion>Saxony</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Rosti, Gianantonio" sort="Rosti, Gianantonio" uniqKey="Rosti G" first="Gianantonio" last="Rosti">Gianantonio Rosti</name>
<affiliation wicri:level="1"><nlm:aff id="aff7">University of Bologna, Bologna, Italy;</nlm:aff>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>University of Bologna, Bologna</wicri:regionArea>
<wicri:noRegion>Bologna</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Nakaseko, Chiaki" sort="Nakaseko, Chiaki" uniqKey="Nakaseko C" first="Chiaki" last="Nakaseko">Chiaki Nakaseko</name>
<affiliation wicri:level="1"><nlm:aff id="aff8">Chiba University Hospital, Chiba, Japan;</nlm:aff>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Chiba University Hospital, Chiba</wicri:regionArea>
<wicri:noRegion>Chiba</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="De Souza, Carmino Antonio" sort="De Souza, Carmino Antonio" uniqKey="De Souza C" first="Carmino Antonio" last="De Souza">Carmino Antonio De Souza</name>
<affiliation wicri:level="1"><nlm:aff id="aff9">University of Campinas, Campinas, Brazil;</nlm:aff>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>University of Campinas, Campinas</wicri:regionArea>
<wicri:noRegion>Campinas</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kalaycio, Matt E" sort="Kalaycio, Matt E" uniqKey="Kalaycio M" first="Matt E." last="Kalaycio">Matt E. Kalaycio</name>
<affiliation wicri:level="2"><nlm:aff id="aff10">Cleveland Clinic, Cleveland, OH;</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Ohio</region>
</placeName>
<wicri:cityArea>Cleveland Clinic, Cleveland</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Meier, Stephan" sort="Meier, Stephan" uniqKey="Meier S" first="Stephan" last="Meier">Stephan Meier</name>
<affiliation wicri:level="1"><nlm:aff id="aff11">Novartis Pharma AG, Basel, Switzerland;</nlm:aff>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Novartis Pharma AG, Basel</wicri:regionArea>
<wicri:noRegion>Basel</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Fan, Xiaolin" sort="Fan, Xiaolin" uniqKey="Fan X" first="Xiaolin" last="Fan">Xiaolin Fan</name>
<affiliation wicri:level="2"><nlm:aff id="aff12">Novartis Pharmaceuticals Corporation, East Hanover, NJ;</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">New Jersey</region>
</placeName>
<wicri:cityArea>Novartis Pharmaceuticals Corporation, East Hanover</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Menssen, Hans D" sort="Menssen, Hans D" uniqKey="Menssen H" first="Hans D." last="Menssen">Hans D. Menssen</name>
<affiliation wicri:level="1"><nlm:aff id="aff11">Novartis Pharma AG, Basel, Switzerland;</nlm:aff>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Novartis Pharma AG, Basel</wicri:regionArea>
<wicri:noRegion>Basel</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Larson, Richard A" sort="Larson, Richard A" uniqKey="Larson R" first="Richard A." last="Larson">Richard A. Larson</name>
<affiliation wicri:level="2"><nlm:aff wicri:cut="; and" id="aff13">University of Chicago, Chicago, IL</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Illinois</region>
</placeName>
<wicri:cityArea>University of Chicago, Chicago</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Hochhaus, Andreas" sort="Hochhaus, Andreas" uniqKey="Hochhaus A" first="Andreas" last="Hochhaus">Andreas Hochhaus</name>
<affiliation wicri:level="1"><nlm:aff id="aff14">Abteilung Hämatologie/Onkologie, Universitätsklinikum Jena, Jena, Thuringia, Germany</nlm:aff>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Abteilung Hämatologie/Onkologie, Universitätsklinikum Jena, Jena, Thuringia</wicri:regionArea>
<wicri:noRegion>Thuringia</wicri:noRegion>
<wicri:noRegion>Thuringia</wicri:noRegion>
<wicri:noRegion>Thuringia</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Blood</title>
<idno type="ISSN">0006-4971</idno>
<idno type="eISSN">1528-0020</idno>
<imprint><date when="2014">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><title>Key Points</title>
<p><list list-type="bullet"><list-item><p>More patients with chronic myeloid leukemia in chronic phase achieve EMR on frontline nilotinib than imatinib.</p>
</list-item>
<list-item><p>EMR failure on frontline nilotinib or imatinib predicts poor outcomes in patients with chronic myeloid leukemia in chronic phase.</p>
</list-item>
</list>
</p>
</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003A09 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 003A09 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Asie |area= AustralieFrV1 |flux= Main |étape= Curation |type= RBID |clé= PMC:4624459 |texte= Early molecular response predicts outcomes in patients with chronic myeloid leukemia in chronic phase treated with frontline nilotinib or imatinib }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/RBID.i -Sk "pubmed:24335106" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd \ | NlmPubMed2Wicri -a AustralieFrV1
This area was generated with Dilib version V0.6.33. |